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ABSTRACT
Background: Connective tissue growth factor (CTGF) is known to play a direct role in fibrosis in various or-
gans as a downstream mediator of TGF-β．
Objective: To evaluate a role in subepithelial fibrosis in the asthmatic airway, we investigated CTGF mRNA
expression and CTGF producing cells in the airways of a murine asthma model with allergic inflammation．
Methods: After repetitive inhalation challenges with ovalbumin (OVA), cell numbers and TGF-β1 concentra-
tions in bronchoalveolar lavage fluid from immunized mice were measured. Collagen deposition in lung tissue
was estimated by measuring hydroxyproline content. CTGF mRNA and GAPDH mRNA levels were determined
by quantitative RT-PCR method. Immunohistochemistry for CTGF with anti-CTGF antibody was performed．
Results: Numbers of eosinophils and TGF-β1 concentration increased markedly in BALF on the 7th day and
14th day after inhalation challenge with OVA. Hydroxyproline content in lung tissue increased significantly on
the 14th day after inhalation challenge of OVA compared to control. The ratio of CTGF mRNAGAPDH mRNA
in lung tissue in mice exposed to OVA increased 10-fold compared to those exposed to saline. Immunohisto-
chemistry revealed that the number of CTGF-positive cells increased in bronchial submucosa after inhalation
challenge of OVA．
Conclusions: Our results suggested that CTGF might be one of the potential molecules involved in subepi-
thelial fibrosis in murine airways with allergic inflammation．
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INTRODUCTION
Airway remodeling in asthma has been characterized
by goblet cell hyperplasia , subepithelial fibrosis ,
smooth muscle hypertrophyhyperplasia and submu-
cosal gland hypertrophyhyperplasia . These struc-
tural changes result in thickening of the airway wall
which induces the maximal degree of airway narrow-
ing when the smooth muscle constricts. In this re-
gard, the airway remodeling has been thought to con-
tribute to the development of airway hyperrespon-
siveness and the progressive impairment of lung
function over time.1,2
To elucidate the mechanism of airway remodeling
in asthma, roles of several growth factors in the struc-
tural changes have been evaluated in asthmatic air-
ways and in experimental animal models with bron-
chial asthma . Several reports have suggested that
thickening of the reticular lamina results from inter-
stitial collagen and fibronectin deposition.3,4
Transforming growth factor-β (TGF-β)is a potent
profibrotic cytokine which stimulates fibroblasts to
promote the synthesis and secretion of collagens and
other extracellular matrix proteins. Ohno et al. dem-
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onstrated that eosinophils express TGF-β mRNA in
the airway of patients with severe asthma.5 Minshall
et al. reported TGF-β mRNA expression correlated
with the thickness of the airway basement mem-
brane.6 These results suggested TGF-β may play a
role in subepithelial fibrosis．
Connective tissue growth factor (CTGF), which is
a cysteine-rich 38-kDa mitogenic peptide, functions as
a downstream mediator of TGF-β action in connective
tissue cells . 7,8 Previous studies demonstrated that
there were CTGF-dependent and CTGF-independent
signaling pathways activated by TGF-β in fibroblasts.9
It is known that CTGF expression was upregulated in
bleomycin-induced lung fibrosis, and idiopathic pul-
monary fibrosis, suggesting that CTGF may play a
role in pulmonary fibrosis.10-12
However, to date, little is understood of the roles of
CTGF in airway remodeling in asthma. To extend the
findings and investigate whether CTGF is involved in
subepithelial fibrosis in asthma, we studied the im-
munohistochemical localization of CTGF protein, and
analyzed the quantitative CTGF mRNA expression
with experimental murine asthma model sensitized
with ovalbumin (OVA).
METHODS
ANIMALS
Female BALBc mice (6―8 wk old) were purchased
from Japan SLC (Shizuoka, Japan). The mice were
housed under specific pathogen-free conditions fol-
lowing a 12-hour light-dark cycle and fed a standard
laboratory diet and given water ad libitum. All experi-
ments described in this study were performed ac-
cording to the guidelines for the care and use of ex-
perimental animals as determined by the Japanese
Association for Laboratory Animal Science in 1987.
IMMUNIZATION AND AEROSOLIZATION PRO-
TOCOL
The mice were sensitized according to the methods
described in a previous paper.13 In brief, mice were
sensitized at days 0 and 5 of the protocol by an intrap-
eritoneal injection of 0.5 ml aluminum hydroxide-
precipitated antigen containing 8 μg OVA ( Sigma
Chemical Co., St. Louis, MO) adsorbed overnight at
4℃ to 4 mg of aluminium hydroxide (Wako Chemical
Co . , Tokyo , Japan ) in phosphate-buffered saline
(PBS). 12 days later, mice were divided into 5 groups
which consisted of 6―8 animals. One group of mice
was killed for analysis as a control without inhalation.
Two groups of the mice were placed in a plastic
chamber (10 cm × 15 cm × 25 cm) and exposed to
aerosolized OVA (5 mgml in 0.9% saline) for 1 h. In
the case of controls, the other 2 groups of the mice
were exposed to 0.9% saline only . The aerosolized
OVA was produced by Pulmo-Aide Compressor
Nebulizer (Devilbiss ) (Sunrise Medical HHG, Inc ,
Somerset, PA) at a flow rate of 5―7 litermin．
COLLECTION AND MEASUREMENT OF SPECI-
MENS
After being exposed to aerosolized saline or OVA
every day over periods of 6 and 13 days, each group
of mice was killed on the 7th and the 14th day , 24
hours after final inhalation, and bronchoalveolar lav-
age fluid (BALF) and lung tissue were collected. To
collect BALF, the lungs were dissected and the tra-
chea was cannulated with a polyethylene tube (Bec-
ton Dickinson, Sparks, MD). The right lungs were
lavaged twice with 0.5 ml PBS, and―0.8 ml of the in-
stilled fluid was consistently recovered. The recov-
ered fluid was centrifuged (300 × g for 6 min) and the
cells were resuspended in 0.5 ml PBS. The total num-
ber of cells was counted using an improved Neubauer
hemocytometer chamber. An air-dried slide prepara-
tion was made of each sample containing 10,000 cells
by cytospin (Cytocentrifuge, Sakura Seiki, Tokyo, Ja-
pan) and stained with May-Grunwald-Giemsa stain .
Differential counts of at least 500 cells were made ac-
cording to standard morphologic criteria. The num-
bers of cells recovered per mouse were then ex-
pressed as the mean and standard error of the mean
(SEM) for each treatment group．
After centrifugation, supernatants were stored at
− 80℃ for measurement of TGF-β1 by ELISA. After
harvesting BALF , the right lungs were frozen at
− 80℃ for measurement of hydroxyproline. The sec-
tions of left lungs were fixed with periodate-lysin-
paraformaldehyde solution at 4℃, and were embed-
ded in OTC-compound in liquid nitrogen for immuno-
histochemistry for CTGF . The other lung tissues
were fixed with formaldehyde and were embedded in
paraffin. These 3-μm-thick sections were stained with
hematoxylin eosin ( HE ) , and Elastica Masson’s
trichrome (EM). In addition, the other parts of left
lungs were stored at − 80℃ for RNA extraction.
ISOLATION OF TOTAL RNA AND REAL-TIME
QUANTITATIVE PCR
Total RNA from tissues was obtained using ISOGEN
(Wako Pure Chemicals, Osaka, Japan), quantitated
by spectrophotometry . The quality of the obtained
RNA was examined by agarose gel electrophresis.
To quantify the mRNA of CTGF and glyceraldehyde-
3-phosphatase dehydrogenase (GAPDH) expression
in murine lungs, quantitative PCR was carried out us-
ing an ABI Prism 7700 Sequence Detector (Perkin-
Elmer Applied Biosystems, Foster City, CA) as previ-
ously described.14
Oligonucleotide PCR primer pairs and fluorogenic
probes for murine CTGF were designed from the
published sequences using Primer Express software
(Perkin-Elmer)(sense primer ; 5’-GTCAACCTCAGA-
CACTGGTTTCG-3 ’ , antisense primer ; 5 ’ -CCACT-
GTTCCAGGAGACTCACC-3 ’ , Taqman probe ; 5 ’ -
[FAM] TCATTAGCGCACAGTGCCAGAACGC
[TAMRA]-3’).15 Primers and labeled probe (VIC) for
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Table 1　Total cel number and cel diferential in BALF of mice after saline and OVA inhalation
OVA, 14th dayOVA, 7th daysaline, 14th daysaline, 7th day
 302.3 ± 47.0＊
 (n = 6)
 297.3 ± 68.8＊
 (n = 6)
 22.1 ± 5.5
 (n = 6)
 12.1 ± 2.3
 (n = 6)
total cels
(× 104/ml)
 73.2 ± 21.5＊
 (24.2 ± 7.1%)＊
 69.9 ± 20.8＊
 (23.5 ± 7.0%)＊
 20.2 ± 1.66
 (91.4 ± 7.5%)
 10.4 ± 0.75 
 (85.6 ± 6.2%)
alveolar 
macrophages
(× 104/ml)
 22.1 ± 10.6＊ 
 (7.3 ± 3.5%) 
 24.7 ± 7.4＊
 (8.3 ± 2.5%)
 1.9 ± 1.7
 (8.6 ± 7.5%)
 1.74 ± 0.75 
 (14.4 ± 6.2%)
lymphocytes 
(× 104/ml)
 207.1 ± 21.2＊
 (68.5 ± 7.0%)＊
 203.1 ± 21.7＊
 (68.3 ± 7.3%)＊
< 0.1%< 0.1%
eosinophils 
(× 104/ml)
< 0.1%< 0.1%< 0.1%< 0.1%neutrophils
< 0.1%< 0.1%< 0.1%< 0.1%epithelial cels
The number of cels in BALF on 7th day and 14th day after saline and OVA inhalation in mice sensitized with OVA. BALF was colected as 
described in “Methods” .Values were expressed as the means ± SEM of 6 mice. ＊p < 0.01 relative to the respective value of saline inhala-
tion
rodent GAPDH were purchased from Perkin-Elmer
Applied Biosystems. Briefly, 100 ng of RNA dissolved
in 10 μl of water from each aliquot of murine lung tis-
sue were denatured at 90℃ for 90 s. Each RNA sam-
ple (100 ng10 μl of water) was mixed in 40 μl of
buffer containing the following reagents for the one-
step RT-PCR reaction : 50 mM KCl, 10 mM Tris-HCl
(pH 8.3), 0.01 mM EDTA, 60 nM Passive Reference 1
(Applied Biosystems), 5 mM MgCl2, 100 nM sense
primer, 100 nM antisense primer, 0.3 mM deoxynu-
cleoside triphosphate (Boehringer), 0.4 Uμl RNase
inhibitor (Promega), 0.4 Uμl Moloney murine leuke-
mia virus RT (Perkin Elmer), 0.0025 Uμl Taq Gold
Polymerase (Perkin Elmer) , and 100 nM Taqman
probe as described above. The fragment of mRNA for
CTGF and GAPDH was reverse transcribed into
cDNA (30 min at 48℃) and amplified by PCR for 40
cycles (15 s at 95℃ and 1 min at 60℃). Whole reac-
tions of the RT-PCR and detection of the fluorescence
emission signal for every PCR cycle were performed
at the same time in a single tube in a sequence detec-
tor (ABI 7700). The minimum PCR cycle to detect the
fluorescent signal was defined as the cycle threshold
(C), which is predictive of the quantity of an input tar-
get fragment.16 The standard curve was obtained be-
tween the fluorescence emission signals and C by
means of duplicated serial dilutions of the total RNA
from murine lung in medium alone. Expression of
CTGF mRNA was normalized to a constitutive ex-
pression of GAPDH mRNA.
ANTIBODIES AND IMMUNOHISTOCHEMICAL
STAINING
We adopted the biotin-streptavidin system using a
Histofine Kit (Nichirei, Tokyo, Japan) for immunohis-
tochemical staining. The sections were deparaffinized
and treated with 0.3% hydrogen peroxide in methanol
for 15 minutes to block endogenous peroxidase activ-
ity. The sections were incubated with 10% normal rab-
bit serum for 30 minutes at room temperature to
block the non-specific antibody reaction . We used
anti-human CTGF rabbit polyclonal antibody which
also reacted with murine CTGF.12 This cross reactiv-
ity was confirmed on western blotting ( data not
shown). The sections were incubated overnight at
4℃ with the primary antibodies. 3’3-diaminobenzidine
(DAB) was used as the chromogenic substrate．
TGF-β1 ASSAY
Murine TGF-β1 concentration in BALF was meas-
ured according to the steps described in a previous
paper.17 BALF was applied to 96-well microtiter plates
coated with chicken anti-human TGF-β1antibody (5
μgml)(R & D Systems, Minneapolis, MN). Bound
TGF-β1 was detected by monoclonal anti-TGF-β1 (1
μgml)(Genzyme), followed by peroxidase-labeled
goat anti-mouse IgG (1 μgml)(Kierkegaard & Perry
Laboratories , Gaithersburg , MD) and tetramethyl-
benzidine reagent (Kierkegaard & Perry). In this as-
say, concentration of total TGF-β1 including both ac-
tive and inactive molecules was measured . Optical
densities were determined at 450 nm and converted
to concentrations (ngml) according to the standard
curve obtained with titrated concentrations of human
recombinant TGF-β1 (R & D Systems). The lower
limit of this method was 7.0 pgml.
HYDROXYPROLINE ANALYSIS
Total collagen content of the right lung was estimated
by an assay of hydroxyproline.18 Briefly, after acid hy-
drolysis of the lung was completed with 6 N HCl at
110℃ for 16 h in a sealed glass tube (Iwaki, Tokyo,
Japan), 50-μl aliquots were added to 1 ml of 1.4% chlo-
ramine T (Sigma Chemical Co., St. Louis, MO), 10％
n-propanol, and 0.5 M sodium acetate, pH 6.0. After
20 min of incubation at room temperature, 1 ml of Er-
lich’s solution (1 M p-dimethylaminobenzaldehyde
in 70% n-propanol , 20% perchloric acid) was added
and allowed to incubate at 65℃ for 15 min. Absor-
bance was measured at 550 nm and the amount of hy-
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Fig. 1　TGF-β1 concentration in BALF after antigen inhala-
tion in BALB/c mice sensitized with OVA. As described in 
“Methods”, after the exposure to aerosolized saline or OVA 
every day over periods of 6 or 13 days, mice were kiled on 
the 7th and the 14th day, and BALF was colected. Values 
are expressed as the means ± SEM of 6―8 mice. A value 
less than 7.0 pg/ml could not be detected. Open column: 
sensitized mice with OVA before inhalation of OVA (0 day); 
gray column: sensitized mice with OVA after saline; black 
column: sensitized mice with OVA after inhalation of OVA. 
＊p < 0.001
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Fig. 2　The content of hydroxyproline in the lungs after anti-
gen inhalation in mice sensitized with OVA. As described in 
“Methods” ,mice were exposed to aerosolized saline or 
OVA successively for 6 or 13 days, and the lungs were ex-
cised from these mice 24 hour after final inhalation of saline 
or OVA. Values are expressed as the means ± SEM of 6 
mice. Open column: sensitized mice with OVA before inhala-
tion of OVA; gray column: sensitized mice with OVA after sa-
line; black column: sensitized mice with OVA after inhalation 
of OVA. ＊p < 0.001
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droxyproline was determined against a standard
curve generated using known concentrations of re-
agent hydroxyproline (Sigma Chemical Co.).
STATISTICAL ANALYSIS
Mann-Whitney U Test was used in the analysis of re-
sults. All values are expressed as means ± SEM. Val-
ues of p < 0.05 were considered statistically signifi-
cant．
RESULTS
NUMBERS OF TOTAL CELLS AND EOSINO-
PHILS IN BALF OF SENSITIZED MICE AFTER IN-
HALATION CHALLENGE OF OVA
While total numbers of cells and eosiophils in BALF
of OVA-sensitized mice showed no change on the 7th
and 14th day after saline inhalation, in contrast, these
increased markedly on the 7th and 14th day after inha-
lation challenge with OVA (Table 1).
TGFβ1 IN BALF OF SENSITIZED MICE AFTER IN-
HALATION CHALLENGE OF OVA
TGFβ1 concentration was very low without inhalation
on the 7th and 14th day in BALF from OVA-sensitized
mice after inhalation of saline . In contrast , TGFβ1
concentration increased markedly on the 7th and 14th
day in BALF from OVA-sensitized mice after inhala-
tion of OVA (Fig. 1).
COLLAGEN CONTENT IN LUNG TISSUES OF
SENSITIZED MICE AFTER INHALATION CHAL-
LENGE OF OVA
Determination of collagen content in lung tissues was
expressed as hydroxyproline content in the tissue .
Hydroxyproline content increased significantly on the
14th day in the lung tissues from OVA-sensitized mice
after inhalation of OVA , compared to those from
OVA-sensitized mice after inhalation of saline (Fig.
2).
CTGF mRNA LEVEL IN LUNG TISSUES FROM
OVA-SENSITIZED MICE AFTER INHALATION OF
OVA
CTGF mRNA levels were determined by quantitative
RT-PCR as described in “Methods” . The ratios of
CTGF mRNAGAPDH mRNA were calculated to ex-
amine the change of CTGF mRNA level in the lung
from OVA-sensitized mice after inhalation of OVA.
The ratios of CTGF mRNAGAPDH mRNA did not
change in the lung of OVA-sensitized mice after inha-
lation of saline. In contrast, these greatly increased
on the 7th and 14th day in the lung of OVA-sensitized
mice after inhalation of OVA (Fig. 3).
HISTOLOGICAL CHANGES IN AIRWAYS OF
SENSITIZED MICE AFTER INHALATION OF OVA
After inhalation of OVA , dramatic histological
changes were observed in the airways of sensitized
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Fig. 3　Expression of CTGF gene in lung tissues after aler-
gen inhalation. The amount of CTGF mRNA in lung tissues 
was quantified by real-time RT-PCR as described in“ Meth-
ods”, and the expression of CTGF genes is represented as 
the ratio of CTGF-specific mRNA copy numbers to those of 
the GAPDH (housekeeping gene). Values are expressed as 
the means ± SEM of 6 mice. Open column: sensitized mice 
with OVA before inhalation of OVA; gray column: sensitized 
mice with OVA after saline; black column: sensitized mice 
with OVA after inhalation of OVA. ＊p < 0.001
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mice . Submucosal cellular infiltration including
eosinophils and mononuclear cells was observed in
submucosa of bronchi and bronchioles (Fig. 4B,4C).
Goblet cell metaplasia occurred in bronchi and bron-
chioles within 7 days after inhalation of OVA, and al-
most all epithelial cells changed into goblet cells on
the 14th day after the inhalation. Fibrous materials in
submucosa of bronchi also became marked on the
14th day after the inhalation as expressed as blue
color in Elastica Masson’s trichrome staining (Fig. 4
F,4G). On the other hand, fibrotic changes were not
observed in alveolar septum. Increase of bronchial
muscle layer became prominent in submucosa.
After 14-day inhalation of saline to sensitized mice,
there were few goblet cells in epithelium and a small
number of infiltrated cells in airway submucosa (Fig.
4D,4H).
IMMUNOHISTOCHEMISTRY FOR CTGF
Some bronchial epithelial cells were weakly stained
in both groups of mice after inhalation of saline (Fig.
5A). However , CTGF positive epithelial cells were
much more prominent in mice after inhalation of
OVA (Fig. 5B) compared to those after inhalation of
saline. Many positive cells were seen in the submu-
cosa of bronchi after OVA inhalation. Smooth muscle
cells and infiltrated round cells were positively
stained in submucosa of bronchi on the 14th day in
the lungs of OVA-sensitized mice after inhalation of
OVA (Fig. 5C). Spindle-like cells were also positively
stained in fibrotic tissue in the submucosa of bronchi
on the 14th day after inhalation of OVA (Fig. 5D).
In Panel E treated with normal rabbit serum in-
stead of anti-CTGF antibody, no positive cells were
detected in airway tissue．
DISCUSSION
The present study demonstrated the increase of
CTGF mRNA level in the lung of OVA-sensitized
mice after repetitive inhalation of OVA. In this murine
asthma model, structural changes occurred, such as
goblet cell metaplasia and collagen deposition in
bronchial submucosa after 13 days of repetitive OVA
inhalation. These results suggest CTGF may play a
role in collagen deposition in the bronchial wall in a
murine model of allergic airway inflammation．
Thickening of basement membrane in the central
airway , which is widely recognized as one of the
structural changes characteristic in asthma, has been
attributed to deposition of extracellular matrix mole-
cules including collagen induced by fibroblast activa-
tion.3 In our murine model, histological study with
EM staining demonstrated an increased level of fi-
brous proteins in bronchial submucosa on 7th and
14th day after antigen inhalation. In addition, collagen
content also increased on the 14th day after antigen
inhalation. We speculated that the delay of the in-
crease of hydroxyproline content in the lung tissue
compared to that of TGF-β1 in BALF was partially
due to the time required for the process including ac-
tivation of TGF-β signaling, collagen gene expression,
collagen synthesis , collagen secretion and collagen
deposition in interstitium. In this time course, no fi-
brotic change was detected in alveolar tissue . We
thought that allergic reactions mainly occurred in
bronchi and bronchioles due to the deposition of
OVA, and this was the reason why fibrotic response
possibly induced by TGF-β1 produced from inflam-
matory cells was observed in the airway not in alveo-
lar tissue. These results suggested that subepithelial
fibrosis in the airway proceeds after14 days with re-
petitive daily antigen inhalation in the airway of OVA-
sensitized mice．
TGF-β, a potent fibrogenic cytokine, has been in-
volved in tissue fibrosis, including pulmonary fibro-
sis.19,20 TGF-β has also been suggested to play an im-
portant role in subepithelial fibrosis by the following
evidence : (a) TGF-β is detected in exaggerated quan-
tities in asthmatic BAL fluid before and after antigen
challenge ; (b) TGF-β is produced by eosinophils and
fibroblasts from patients with severe and mild asthma
and (c) TGF-β1 expression correlates with basement
membrane thickness and fibroblast number andor
disease severity.5,6,21,22 The present study confirmed
the increase of TGF-β1 in BALF during antigen inha-
lation to sensitized mice with OVA, suggesting that
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Fig. 4　Histological changes in sensitized murine lungs after inhalation of OVA. Panels A, B, 
C and D are sections with HE staining (× 20 magnification), and E, F, G and H are sections 
stained with EM (× 25). Panels A and E: Bronchial tissue from the sensitized mouse before 
OVA inhalation; Panels B and F: Bronchial tissue from the sensitized mouse on the 7th day af-
ter OVA inhalation; Panels C and G: Bronchial tissue from the sensitized mice on the 14th day 
after OVA inhalation. Panels D and H: Bronchial tissue from the sensitized mice on the 14th 
day after saline inhalation. In Panels B and C, submucosal celular infiltration was prominent 
(internal scale bar =  50 μm). In Panel E, no goblet cel was observed in bronchial epithelium. 
In contrast, almost al bronchial epithelial cels were replaced by goblet cels (＊) in Panels F 
and G. In Panels F and G, bronchial epithelial basement membrane, colored blue, was promi-
nent and submucosal colagen deposition expressed by a blue color appeared to be increased 
in Panel F (internal scale bar = 40 μm). In Panels D and H, there were few goblet cels in epi-
thelium and a smal number of infiltrated cels in airway submucosa. In addition, submucosal 
colagen deposition was not detected. Arows indicate infiltrated cels and arow-heads indi-
cate smooth muscle.
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Fig. 5　Immunohistochemistry for CTGF. Bronchial tissues excised from the sensitized mice were 
stained with anti CTGF antibody as described in“Methods”. Positive signals were expressed by a brown 
color. Panel A: on the 7th day after daily saline inhalation (× 20); Panel B: on the 7th day after daily OVA in-
halation (× 20); Panel C and Panel D: on the 14th day after daily OVA inhalation (× 50). Panel E: bronchial 
tissue on the 14th day after daily OVA inhalation (×50) as a control with use of normal rabbit serum for 
blocking and without anti CTGF antibody. In Panels A, a smal number of cels were weakly stained and 
sparse in bronchial epithelium (＊). In Panel B, almost al bronchial epithelial cels (＊) were stained 
strongly (internal scale bar = 50 μm). In Panel C, epithelial cels (＊), submucosal smooth muscle (arow-
heads) and infiltrated cels (arows) were stained. In Panel D, round cels (arows) and spindle-like cels 
(arow-heads) were stained in the airway submucosa (internal scale bar = 20 μm). In Panel E, no positive 
cels were detected in airway submucosa, suggesting that normal rabbit serum did not stain falsely 
positive.
TGF-β may play an important role in collagen deposi-
tion in bronchial submucosa of mice with allergic in-
flammation．
CTGF is a cysteine-rich secretory protein of 36―38
kDa, which is composed of 349 amino acid residues,
and its gene belongs to the CCN family.23,24 Because
of its ability to induce the expression of the extracel-
lular matrix (ECM) molecules, CTGF has been pro-
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posed to play an important role in connective tissue
cell proliferation and ECM deposition as one of the
mediators of TGF-β . 25 Increased CTGF expression
has been shown in a variety of human and experi-
mental diseases characterized by fibrosis, including
studies in the kidney, skin, blood vessels, lung, and
liver.10,12,26,27 This present study demonstrated the in-
crease of CTGF mRNA levels with real time quantita-
tive PCR and the increased number of CTGF contain-
ing cells in airways of our murine model. Combined
with previous results , our findings indicated that
CTGF may play a role in collagen deposition in bron-
chial submucosa of experimental murine model with
allergic airway inflammation.
Recently, Abreu et al. reported that CTGF directly
binds TGF-β1 through its cysteine-rich domain and
potentiates TGF-β1 receptor binding and signaling.28
This new type of interaction between CTGF and TGF-
β1 may work widely in tissue fibrosis of multiple or-
gans including pulmonary fibrosis in which simulta-
neous induction of CTGF and TGF-β1 were evalu-
ated. In our model, induction of TGF-β1 protein was
evaluated and induction of CTGF protein was
strongly suggested because of up-regulation of CTGF
mRNA level. In the present study, we could not meas-
ure CTGF protein concentration because an appropri-
ate anti-mouse CTGF antibody was not available .
However, to evaluate the interactions between CTGF
and TGF-β1, both CTGF and TGF-β1 protein levels
need to be studied．
Immunohistochemical staining demonstrated local-
ization of CTGF protein in murine airways when ex-
posed to saline or OVA. We used anti-human CTGF
rabbit polyclonal antibody which also reacted with
murine CTGF. Bronchial epithelial cells in mice ex-
posed to saline for 6 or 13 days were weakly stained
with anti-CTGF antibody. We also could detect CTGF
mRNA expression in lung tissues of the mice ex-
posed to saline for 6 or 13 days. These results sug-
gested that bronchial epithelial cells constitutively ex-
press CTGF mRNA and produce CTGF. In contrast
to the mice exposed to saline , bronchial epithelial
cells were strongly stained in those exposed to OVA.
In addition, round cells and spindle-like cells in sub-
mucosa were positively stained. Smooth muscle cells
were also found to be positively stained in bronchial
submucosa. Fan et al. reported that CTGF was ex-
pressed in vascular smooth muscle cells and might
play a role in migration and proliferation of these
cells.30 Recently Burgess et al. reported that TGF-β
specifically induces mRNA and protein for connective
tissue growth factor in airway smooth muscle , and
the connective tissue growth factor response is
greater in airway smooth muscle cultured from pa-
tients with asthma compared with patients without
asthma.31 This result suggested that CTGF may also
play a role in migration and proliferation of airway
smooth muscle cells in asthma.
Ricupero et al. reported that PGE2 reduced mRNA
and protein level of CTGF in fibroblasts stimulated by
TGF-β.32 This down-regulation of CTGF mRNA level
was thought to be induced by elevated intracellular
cAMP levels.30 On the other hand, Rishikof et al. re-
ported that IL-4 attenuated the TGF-β-stimulated in-
duction of CTGF mRNA expression in human lung fi-
broblasts.33 Having taken these results into consid-
eration, CTGF mRNA level was thought to be influ-
enced by PGE2 and IL-4 produced in murine allergic
airway inflammation . In addition , we reported re-
cently that myofibroblasts contained CTGF in fibrotic
pulmonary tissue of patients with idiopathic pulmo-
nary fibrosis . 12 This result suggested spindle-like
cells in submucosa to be myofibroblasts . On the
other hand, round cells were not evaluated. To date,
TGF-β is known to be produced by bronchial epithe-
lial cells, eosinophils, macrophages and fibroblasts,
especially myofibroblasts. These consequences sug-
gested TGF-β produced by these cells may be in-
volved in the induction of the CTGF gene in the air-
way in an autocrine or paracrine manner . Further-
more, it is feasible to assume that CTGF overpro-
duced in the airway may be involved in proliferation
and activation of fibroblasts which cause extracellular
matrix deposition in the submucosa of the airway．
In conclusion, CTGF may be one of potential mole-
cules involved in subepithelial fibrosis in murine air-
ways with allergic inflammation.
ACKNOWLEDGEMENTS
The authors would like to thank Ms C Kyoda, Miss
M Shibanai and Miss M Niisato for technical assis-
tance, and are grateful to Mike Unher for his critical
reading of the manuscript.
This work is supported by Grant-in-Aid for Scien-
tific Research, The Ministry of Education, Science,
Sports and Culture, in Japan．
REFERENCES
1. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC. A
model of airway narrowing in asthma and in chronic ob-
structive pulmonary disease. Am. Rev. Respir. Dis. 1992;
145:1251-1258.
2. Lange P, Parner J, Vestbo J, Schnohr P, Jensen GA. 15-
year follow-up study of ventilatory function in adults with
asthma. N. Engl. J. Med. 1998;339:1194-1200.
3. Roche WR, Beasley R, Williams JH, Holgate ST. Subepi-
thelial fibrosis in the bronchi of asthmatics. Lancet 1989;
1:520-524.
4. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling
in asthma. J. Clin. Invest. 1999;104:1001-1006.
5. Ohno I, Nitta Y, Yamauchi K et al. Transforming growth
factor β1 (TGF β1) gene expression by eosinophils in
asthmatic airway inflammation. Am. J. Respir. Cell Mol.
Biol. 1996;15:404-409.
6. Minshall EM, Leung DY, Martin RJ et al. Eosinophil-
associated TGF-β1 mRNA expression and airways fibrosis
in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 1997;
114 Allergology International Vol 54, No1, 2005 www.js-allergol.gr.jp
Piao HM et al.
17:326-333.
7. Igarashi A, Okochi H, Bradham DM, Grotendorst GR.
Regulation of connective tissue growth factor gene ex-
pression in human skin fibroblasts and during wound re-
pair.Mol. Biol. Cell. 1993;4:637-645.
8. Frazier K, Williams S, Kothapalli D, Klapper H, Groten-
dorst GR. Stimulation of fibroblast cell growth , matrix
production, and granulation tissue formation by connec-
tive tissue growth factor. J. Invest. Dermatol. 1996;107:
404-411.
9. Grotendorst GR. Connective tissue growth factor : a me-
diator of TGF-β action on fibroblasts. Cytokine & Growth
Factor Reviews 1997;8:171-179.
10. Lasky JA, Ortiz LA, Tonthat B et al. Connective tissue
growth factor mRNA expression is upregulated in
bleomycin-induced lung fibrosis. Am. J. Physiol. 1998;275
(2 Pt 1):L365-371.
11. Allen JT, Knight RA, Bloor CA, Spiteri MA. Enhanced
insulin-like growth factor binding protein-related protein
2 (connective tissue growth factor) expression in patients
with idiopathic pulmonary fibrosis and pulmonary sarcoi-
dosis. Am. J. Respir. Cell Mol. Biol. 1999;21:693-700.
12. Pan LH, Yamauchi K, Uzuki M et al. Type II alveolar epi-
thelial cells and interstitial fibroblasts express connective
tissue growth factor in IPF. Eur. Respir. J. 2001;17:1220-
1227.
13. Ohkawara Y, Lei XF, Stampfli MR et al. Cytokine and
eosinophil responses in the lung, peripheral blood and
bone marrow compartments in a murine model of
allergen-induced airways inflammation. Am. J. Respir. Cell
Mol. Biol. 1997;16:510-520.
14. Martell M, Gomez J, Esteban JI et al. High-throughput
real-time reverse transcription-PCR quantitation of hepati-
tis C virus RNA. J. Clin. Microbiol. 1999;37:327-332.
15. Ryseck RP, Macdonald-Bravo H, Mattei MG, Bravo R.
Structure, mapping, and expression of fisp-12, a growth
factor-inducible gene encoding a secreted cysteine-rich
protein. J. Cell Growth Differ. 1991;2:225-233.
16. Heid CA, Stevens J, Livak KJ, Williams PM. Real time
quantitative PCR. Genome. Res. 1996;6:986-994.
17. Haneda K, Sano K, Tamura G et al. Transforming growth
factor-beta secreted from CD4 (+) T cells ameliorates
antigen-induced eosinophilic inflammation. A novel high-
dose tolerance in the trachea. Am. J. Respir. Cell Mol.
Biol. 1999;21:268-274.
18. Woessner JF. The determination of hydroxyproline in tis-
sue and protein samples containing small proportions of
this amino acid. Arch. Biochem. Biophys. 1961;93:440-447.
19. Khalil N, O’Connor RN, Unruh HW et al. Increased pro-
duction and immunohistochemical localization of trans-
forming growth factor-β in idiopathic pulmonary fibrosis.
Am. J. Respir. Cell Mol. Biol. 1991;5:155-162.
20. Border W, Noble N. Transforming growth factor in tissue
fibrosis. N. Engl. J. Med. 1994;331:1286-1292.
21. Redington AE, Madden J, Frew AJ et al. Transforming
growth factor-beta 1 in asthma. Measurement in bron-
choalveolar lavage fluid. Am. J. Respir. Crit. Care Med.
1997;156 (2 Pt 1):642-647.
22. Vignola AM, Chanez P, Chiappara G et al. Transforming
growth factor-β expression in mucosal biopsies in asthma
and chronic bronchitis. Am. J. Respir. Crit. Care Med.
1997;156:591-599.
23. Brigstock DR. The connective tissue growth factor
cysteine-rich 61nephroblastoma overexpressed (CCN)
family. Endocr. Rev. 1999;20:189-206.
24. Takigawa M. Physiological roles of connective tissue
growth factor (CTGFHcs24) : promotion of endochon-
dral ossification, angiogenesis and tissue remodeling. In :
Ikada Y , Y Shimizu (eds) . Tissue Engineering for Thera-
peutic Use 4. Amsterdam:Elsevier, 2000;1-13.
25. Kothapalli D, Frazier KS, Welply A, Segarini PR, Groten-
dorst GR. Transforming growth factor β induces
anchorage-independent growth of NRK fibroblasts via a
connective tissue growth factor-dependent signaling path-
way. Cell Growth Differ. 1997;8:61-68.
26. Yokoi H, Mukoyama M, Sugawara A et al. Role of con-
nective tissue growth factor in fibronectin expression and
tubulointerstitial fibrosis. Am. J. Physiol. Renal. Physiol.
2002;282:F933-942.
27. Abou-Shady M, Friess H, Zimmermann A et al. Connec-
tive tissue growth factor in human liver cirrhosis. Liver
2000;20:296-304.
28. Abreu JG, Ketpura NI, Reversade B, De Robertis EM.
Connective-tissue growth factor (CTGF) modulates cell
signalling by BMP and TGF-β. Nat. Cell Biol. 2002;4:599-
604.
29. Fan WH, Pech M, Karnovsky MJ. Connective tissue
growth factor (CTGF) stimulates vascular smooth muscle
cell growth and migration in vitro. Eur. J. Cell Biol. 2000;
79:915-923.
30. Burgess JK, Johnson PR, Ge Q et al. Expression of con-
nective tissue growth factor in asthmatic airway smooth
muscle cells. Am. J. Respir. Crit. Care Med. 2003;167:71-
77.
31. Rishikof DC, Ricupero DA, Kuang PP, Liu H, Goldstein
RH. Interleukin-4 regulates connective tissue growth fac-
tor expression in human lung fibroblasts. J. Cell. Biochem.
2002;85:496-504.
32. Ricupero DA, Rishikof DC, Kuang PP, Poliks CF, Gold-
stein RH. Regulation of connective tissue growth factor
expression by prostaglandin E (2). Am. J. Physiol. 1999;
277:L1165-1171.
33. Duncan MR, Frazier KS, Abramson S et al. Connective
tissue growth factor mediates transforming growth factor
beta-induced collagen synthesis : down-regulation by
cAMP. FASEB J. 1999;13:1774-1786.
Allergology International Vol 54, No1, 2005 www.js-allergol.gr.jp 115
CTGF Expression in Allergic Airway
